Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bar (Tel-Aviv, Israel). Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease. International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care

Member's Comments

No comment yet.

Related content which might interest you: Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001 Treatment of limited disease small cell lung cancer: the multidisciplinary team Source: Eur Respir J, 50 (2) 1700422; 10.1183/13993003.00422-2017 Year: 2017 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020 Year: 2020 Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Surgical management of patients with small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients Source: Annual Congress 2003 - Lung cancer management and prognosis Year: 2003 Rates of treatment response and median survival in advanced non small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004 Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Small cell lung cancer patients and their responses to treatment Source: Eur Respir J 2004; 24: Suppl. 48, 301s Year: 2004 Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Radiotherapy in small cell lung cancer: patient options Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Why can initial treatment of localised lung cancer fail? Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 The need for early MDT assessment of lung cancer patients presenting with pain Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 Systemic treatment of small cell lung cancer Source: Annual Congress 2008 - PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer) Year: 2008